MediciNova Interest Income from 2010 to 2026

MNOV Stock

USD 1.64 0.02 1.20%

MediciNova Interest Income yearly trend continues to be fairly stable with very little volatility. Interest Income is likely to outpace its year average in 2026. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

325 K

Current Value

340.9 K

Quarterly Volatility

167.7 K

Covid

Interest Hikes

Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.3 M or Research Development of 7.8 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.

Build AI portfolio with MediciNova Stock

Check out the analysis of MediciNova Correlation against competitors.

For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.

The evolution of Interest Income for MediciNova provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how MediciNova compares to historical norms and industry peers.

Latest MediciNova's Interest Income Growth Pattern

Below is the plot of the Interest Income of MediciNova over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. MediciNova's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

MediciNova Interest Income Regression Statistics

	Arithmetic Mean	664,218
	Geometric Mean	233,236
	Coefficient Of Variation	115.78
	Mean Deviation	669,728
	Median	145,210
	Standard Deviation	769,036
	Sample Variance	591.4B
	Range	2M
	R-Value	0.85
	Mean Square Error	175.9B
	R-Squared	0.72
	Significance	0.000016
	Slope	129,332
	Total Sum of Squares	9.5T

MediciNova Interest Income History

	2026	2 M
	2025	1.9 M
	2024	1.7 M
	2023	1.8 M
	2022	809.7 K
	2021	143.6 K
	2020	361.2 K

Other Fundumenentals of MediciNova

Net Interest Income

MediciNova Interest Income component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Net Debt	Accounts Payable	Short Term Investments	Total Current Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Short Term Debt	Intangible Assets	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Net Receivables	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	-0.74	-0.05	-0.86	0.21	0.23	0.98	0.88	-0.51	-0.02	0.29	-0.3	-0.47	0.94	0.86	-0.78	-0.17	0.93	0.93	0.56
Total Stockholder Equity	1.0		-0.71	-0.09	-0.86	0.2	0.24	0.99	0.88	-0.46	-0.02	0.25	-0.31	-0.43	0.96	0.87	-0.78	-0.11	0.93	0.93	0.55
Retained Earnings	-0.74	-0.71		-0.35	0.56	-0.35	-0.16	-0.64	-0.85	0.88	-0.02	-0.43	0.1	0.89	-0.63	-0.69	0.65	0.22	-0.55	-0.54	-0.52
Total Liab	-0.05	-0.09	-0.35		0.14	0.01	-0.06	-0.1	0.01	-0.67	0.35	-0.1	0.67	-0.67	-0.26	-0.28	0.35	0.3	-0.27	-0.25	-0.38
Net Debt	-0.86	-0.86	0.56	0.14		-0.31	0.14	-0.86	-0.72	0.3	0.08	-0.19	0.29	0.28	-0.85	-0.74	0.69	0.13	-0.82	-0.82	-0.48
Accounts Payable	0.21	0.2	-0.35	0.01	-0.31		-0.14	0.16	0.4	-0.24	-0.22	0.31	-0.23	-0.21	0.3	0.41	-0.51	-0.19	0.07	0.05	0.36
Short Term Investments	0.23	0.24	-0.16	-0.06	0.14	-0.14		0.25	0.22	-0.06	-0.24	-0.08	-0.31	-0.03	0.2	0.24	-0.29	0.09	0.23	0.22	0.21
Total Current Assets	0.98	0.99	-0.64	-0.1	-0.86	0.16	0.25		0.82	-0.39	0.01	0.11	-0.28	-0.35	0.93	0.8	-0.73	-0.02	0.93	0.93	0.45
Common Stock	0.88	0.88	-0.85	0.01	-0.72	0.4	0.22	0.82		-0.61	-0.02	0.43	-0.33	-0.61	0.9	0.93	-0.81	-0.14	0.7	0.68	0.67
Property Plant Equipment	-0.51	-0.46	0.88	-0.67	0.3	-0.24	-0.06	-0.39	-0.61		-0.16	-0.39	-0.21	0.96	-0.35	-0.39	0.33	0.15	-0.3	-0.29	-0.27
Current Deferred Revenue	-0.02	-0.02	-0.02	0.35	0.08	-0.22	-0.24	0.01	-0.02	-0.16		-0.26	0.79	-0.22	-0.16	-0.27	0.48	0.32	-0.18	-0.14	-0.6
Good Will	0.29	0.25	-0.43	-0.1	-0.19	0.31	-0.08	0.11	0.43	-0.39	-0.26		-0.33	-0.38	0.32	0.53	-0.48	-0.82	0.28	0.23	0.76
Short Term Debt	-0.3	-0.31	0.1	0.67	0.29	-0.23	-0.31	-0.28	-0.33	-0.21	0.79	-0.33		-0.28	-0.48	-0.58	0.75	0.41	-0.42	-0.38	-0.79
Intangible Assets	-0.47	-0.43	0.89	-0.67	0.28	-0.21	-0.03	-0.35	-0.61	0.96	-0.22	-0.38	-0.28		-0.3	-0.35	0.28	0.11	-0.25	-0.24	-0.23
Net Tangible Assets	0.94	0.96	-0.63	-0.26	-0.85	0.3	0.2	0.93	0.9	-0.35	-0.16	0.32	-0.48	-0.3		0.95	-0.85	-0.14	0.88	0.87	0.68
Capital Surpluse	0.86	0.87	-0.69	-0.28	-0.74	0.41	0.24	0.8	0.93	-0.39	-0.27	0.53	-0.58	-0.35	0.95		-0.91	-0.29	0.78	0.75	0.84
Deferred Long Term Liab	-0.78	-0.78	0.65	0.35	0.69	-0.51	-0.29	-0.73	-0.81	0.33	0.48	-0.48	0.75	0.28	-0.85	-0.91		0.42	-0.76	-0.73	-0.86
Net Receivables	-0.17	-0.11	0.22	0.3	0.13	-0.19	0.09	-0.02	-0.14	0.15	0.32	-0.82	0.41	0.11	-0.14	-0.29	0.42		-0.29	-0.25	-0.62
Net Invested Capital	0.93	0.93	-0.55	-0.27	-0.82	0.07	0.23	0.93	0.7	-0.3	-0.18	0.28	-0.42	-0.25	0.88	0.78	-0.76	-0.29		1.0	0.57
Net Working Capital	0.93	0.93	-0.54	-0.25	-0.82	0.05	0.22	0.93	0.68	-0.29	-0.14	0.23	-0.38	-0.24	0.87	0.75	-0.73	-0.25	1.0		0.52
Capital Stock	0.56	0.55	-0.52	-0.38	-0.48	0.36	0.21	0.45	0.67	-0.27	-0.6	0.76	-0.79	-0.23	0.68	0.84	-0.86	-0.62	0.57	0.52

Click cells to compare fundamentals

About MediciNova Financial Statements

MediciNova investors use historical fundamental indicators, such as MediciNova's Interest Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MediciNova. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	1.9 M	2 M
Net Interest Income	1.9 M	2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

MediciNova Interest Income from 2010 to 2026

Latest MediciNova's Interest Income Growth Pattern

MediciNova Interest Income Regression Statistics

MediciNova Interest Income History

Other Fundumenentals of MediciNova

MediciNova Interest Income component correlations

About MediciNova Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for MediciNova Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY